Home
Stock
ETF
Institutional Holdings
Compound interest
Blog
Support Me
Login
Join us
Français
English
HKSE
/
Healthcare
/
Biotechnology
/
1541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
1541.HK
Summary
30-Y Financials
Dividend
Analyst
Peer analysis
Key metrics
Ownership / Senat
Dividend historical
Dividend payout ratio
0.00
%
Dividend split
Date
Split
